Importance of the ICRU Bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis

Late morbidity after pelvic radiotherapy includes urinary side effects which may significantly impact patients quality of life (QoL) [1]. For locally advanced cervical cancer (LACC), the introduction of image-guided adaptive brachytherapy (IGABT) has led to a decrease in side effects compared to two-dimensional brachytherapy (BT) [2,3]. Disease control and overall survival are improved [4], but urinary morbidity still represents a burden for cancer survivors [5].

Source: Radiotherapy and Oncology - October 13, 2020 Category: Radiology Authors: Sofia Spampinato, Lars U. Fokdal, Richard P ötter, Christine Haie-Meder, Jacob C. Lindegaard, Maximilian P. Schmid, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Umesh Mahantshetty, Barbara Segedin, Kjersti Bruheim, Peter Hoskin, Bhavana Rai, Fleur Huang, R Tags: Original Article Source Type: research